Marshall Wace North America Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$188M |
| 2 |
Amazon
AMZN
|
+$137M |
| 3 |
Adobe
ADBE
|
+$110M |
| 4 |
EA
Electronic Arts
EA
|
+$110M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$131M |
| 2 |
Microsoft
MSFT
|
+$129M |
| 3 |
Visa
V
|
+$119M |
| 4 |
Booking.com
BKNG
|
+$86M |
| 5 |
Humana
HUM
|
+$82.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.67% |
| 2 | Technology | 15.37% |
| 3 | Consumer Discretionary | 10.44% |
| 4 | Industrials | 8.59% |
| 5 | Financials | 8.05% |
Similar funds
Marshall Wace North America's Q1 2019 Portfolio in Review
As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.
- Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
- Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
- Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
- Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
- Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
- Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
- Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.
Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.